[1]
via crossref
|
Definitions and Diagnosis of Pulmonary Hypertension
Marius M. Hoeper, Harm Jan Bogaard, Robin Condliffe, Robert Frantz, Dinesh Khanna, Marcin Kurzyna, David Langleben, Alessandra Manes (+ more)
2013
Journal of the American College of Cardiology
doi:10.1016/j.jacc.2013.10.032
pmid:24355641
|
web.archive.org [PDF]
|
[1]
via crossref
|
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Galiè N
2015
Eur Heart J
volume:46
|
|
[1]
via crossref
|
Primary Pulmonary Hypertension with Emphasis on its Etiology and Treatment
O. STORSTEIN, L. EFSKIND, C. MÜLLER, R. ROKSETH, S. SANDER
2009
Acta Medica Scandinavica
doi:10.1111/j.0954-6820.1966.tb05449.x
|
|
[1]
via crossref
|
Primary pulmonary hypertension: natural history and the importance of thrombosis.
V Fuster, P M Steele, W D Edwards, B J Gersh, M D McGoon, R L Frye
1984
Circulation
doi:10.1161/01.cir.70.4.580
pmid:6148159
|
web.archive.org [PDF]
|
[1]
via crossref
|
Coagulation and anticoagulation in pulmonary arterial hypertension
Berger G
2009
Isr Med Assoc J
volume:11
|
|
[1]
via crossref
|
Coagulation and Fibrinolytic Profiles in Patients With Severe Pulmonary Hypertension
Carolyn H. Welsh, Kathryn L. Hassell, David B. Badesch, David C. Kressin, Richard A. Marlar
1996
Chest
doi:10.1378/chest.110.3.710
pmid:8797416
|
|
[1]
via crossref
|
Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)CLINICAL PERSPECTIVE
Ioana R. Preston, Kari E. Roberts, Dave P. Miller, Ginny P. Sen, Mona Selej, Wade W. Benton, Nicholas S. Hill, Harrison W. Farber
2015
Circulation
doi:10.1161/circulationaha.115.018435
pmcid:PMC4689180
pmid:26510696
|
web.archive.org [PDF]
|
[1]
via crossref
|
Anticoagulation and Survival in Pulmonary Arterial HypertensionClinical Perspective
Karen M. Olsson, Marion Delcroix, H. Ardeschir Ghofrani, Henning Tiede, Doerte Huscher, Rudolf Speich, Ekkehard Grünig, Gerd Staehler (+ more)
2013
Circulation
doi:10.1161/circulationaha.113.004526
pmid:24081973
|
web.archive.org [PDF]
|
[1]
via crossref
|
Oral Anticoagulant Therapy
Walter Ageno, Alexander S. Gallus, Ann Wittkowsky, Mark Crowther, Elaine M. Hylek, Gualtiero Palareti
2012
Chest
doi:10.1378/chest.11-2292
pmcid:PMC3278051
pmid:22315269
|
web.archive.org [PDF]
|
[1]
via crossref
|
Frequency of adverse events in patients with poor anticoagulation: a meta-analysis
N. Oake, D. A. Fergusson, A. J. Forster, C. van Walraven
2007
CMAJ - Canadian Medical Association Journal
doi:10.1503/cmaj.061523
pmcid:PMC1867836
pmid:17515585
|
web.archive.org [PDF]
|
[1]
via crossref
|
Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension
Ivo R. Henkens, Thomas Hazenoot, Anco Boonstra, Menno V. Huisman, Anton Vonk-Noordegraaf
2012
European Respiratory Journal
doi:10.1183/09031936.00039212
pmid:22936704
|
web.archive.org [PDF]
|
[1]
via crossref
|
Clinical implications of haemoptysis in patients with pulmonary arterial hypertension
Jose Cantu, Degang Wang, Zeenat Safdar
2012
International journal of clinical practice
doi:10.1111/ijcp.12004
pmcid:PMC4001782
pmid:22943513
|
web.archive.org [PDF]
|
[1]
via crossref
|
Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population
M Jones
2005
Heart
doi:10.1136/hrt.2004.042465
pmcid:PMC1768813
pmid:15772203
|
web.archive.org [PDF]
|
[1]
via crossref
|
Comparison of Outcomes Among Patients Randomized to Warfarin Therapy According to Anticoagulant Control
Harvey D. White
2007
Archives of Internal Medicine
doi:10.1001/archinte.167.3.239
pmid:17296878
|
web.archive.org [PDF]
|
[1]
via crossref
|
Bleeding events in pulmonary arterial hypertension
C. F. Opitz, W. Kirch, E. A. Mueller, D. Pittrow
2009
European Journal of Clinical Investigation
doi:10.1111/j.1365-2362.2009.02122.x
pmid:19335748
|
|
[1]
via crossref
|
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
None
2013
New England Journal of Medicine
doi:10.1056/nejmoa1306638
pmid:23991658
|
web.archive.org [PDF]
|
[1]
via crossref
|
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano, Christian T. Ruff, Eugene Braunwald, Sabina A. Murphy, Stephen D. Wiviott, Jonathan L. Halperin, Albert L. Waldo, Michael D. Ezekowitz (+ more)
2013
New England Journal of Medicine
doi:10.1056/nejmoa1310907
pmid:24251359
|
web.archive.org [PDF]
|
[1]
via crossref
|
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger, John H. Alexander, John J.V. McMurray, Renato D. Lopes, Elaine M. Hylek, Michael Hanna, Hussein R. Al-Khalidi, Jack Ansell (+ more)
2011
New England Journal of Medicine
doi:10.1056/nejmoa1107039
pmid:21870978
|
web.archive.org [PDF]
|
[1]
via crossref
|
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg, Guohua Pan, Daniel E. Singer, Werner Hacke, Günter Breithardt, Jonathan L. Halperin (+ more)
2011
New England Journal of Medicine
doi:10.1056/nejmoa1009638
pmid:21830957
|
web.archive.org [PDF]
|
[1]
via crossref
|
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, John Eikelboom, Jonas Oldgren, Amit Parekh, Janice Pogue, Paul A. Reilly (+ more)
2009
New England Journal of Medicine
doi:10.1056/nejmoa0905561
pmid:19717844
|
web.archive.org [PDF]
|
[1]
via crossref
|
Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA
M. Wieloch, A. Sjalander, V. Frykman, M. Rosenqvist, N. Eriksson, P. J. Svensson
2011
European Heart Journal
doi:10.1093/eurheartj/ehr134
pmid:21616951
|
web.archive.org [PDF]
|
[1]
via crossref
|
Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study
L. Friberg, M. Rosenqvist, G. Y. H. Lip
2012
Circulation
doi:10.1161/circulationaha.111.055079
pmid:22514252
|
web.archive.org [PDF]
|
[1]
via crossref
|
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
N. S. Abraham, S. Singh, G. C. Alexander, H. Heien, L. R. Haas, W. Crown, N. D. Shah
2015
The BMJ (British Medical Journal)
doi:10.1136/bmj.h1857
pmcid:PMC4413863
pmid:25910928
|
web.archive.org [PDF]
|
[1]
via crossref
|
Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism
Clive Kearon, Jeffrey S. Ginsberg, Michael J. Kovacs, David R. Anderson, Philip Wells, Jim A. Julian, Betsy MacKinnon, Jeffrey I. Weitz (+ more)
2003
New England Journal of Medicine
doi:10.1056/nejmoa035422
pmid:12917299
|
|
[1]
via crossref
|
Gastrointestinal hemorrhage in patients with systemic sclerosis and CREST syndrome
Andrea Duchini, SandraL. Sessoms
1998
American Journal of Gastroenterology
doi:10.1111/j.1572-0241.1998.00462.x
pmid:9732924
|
|
[1]
via crossref
|
Medical Therapy For Pulmonary Arterial Hypertension
David B. Badesch, Steve H. Abman, Gregory S. Ahearn, Robyn J. Barst, Douglas C. McCrory, Gerald Simonneau, Vallerie V. McLaughlin
2004
Chest
doi:10.1378/chest.126.1_suppl.35s
pmid:15249494
|
web.archive.org [PDF]
|
[1]
via crossref
|
Risk of Direct Oral Anticoagulant Bioaccumulation in Patients with Pulmonary Hypertension
Laurence Gabriel, Xavier Delavenne, Pierrick Bedouch, Chahéra Khouatra, Hélène Bouvaist, Jean-François Cordier, Jean-François Mornex, Christophe Pison (+ more)
2016
Respiration
doi:10.1159/000445122
pmid:27083008
|
web.archive.org [PDF]
|
[1]
via crossref
|
Thrombotic Arteriopathy and Anticoagulation in Pulmonary Hypertension
Sindhu R. Johnson, John T. Granton, Sanjay Mehta
2006
Chest
doi:10.1016/s0012-3692(15)51873-4
pmid:16899857
|
|
[1]
via crossref
|
Venous Thromboembolism
Michele G. Beckman, W. Craig Hooper, Sara E. Critchley, Thomas L. Ortel
2010
American Journal of Preventive Medicine
doi:10.1016/j.amepre.2009.12.017
pmid:20331949
|
|
[1]
via crossref
|
Incidence of and Mortality from Venous Thromboembolism in a Real-world Population: The Q-VTE Study Cohort
Vicky Tagalakis, Valérie Patenaude, Susan R. Kahn, Samy Suissa
2013
American Journal of Medicine
doi:10.1016/j.amjmed.2013.02.024
pmid:23830539
|
|